KR · ai · biotech · drug discovery
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Feb 2026 · $29M
Korea Development Bank (KDB), InterVest, Mirae Asset Securities, PATHWAY Investment, DAYLI Partners, Korea Investment & Securities, NCORE Ventures, SL Investment, SneakPeek Investments, Yuanta Investment
Reported by TechStartups
Missing a round, or an investor who was in one? Tell us.